Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CCNC | P24863 | 1/20 | 0.33 |
| ▸ | CDK8 | P49336 | 1/20 | 0.33 |
| ▸ | TYMS | P04818 | 9/20 | 0.33 |
| ▸ | DHFR | P00374 | 2/20 | 0.33 |
| ▸ | DDAH1 | O94760 | 1/20 | 0.31 |
| ▸ | NOS1 | P29475 | 1/20 | 0.31 |
| ▸ | CDC7 | O00311 | 1/20 | 0.31 |
| ▸ | MMP1 | P03956 | 1/20 | 0.30 |
| ▸ | MMP2 | P08253 | 1/20 | 0.30 |
| ▸ | MMP9 | P14780 | 1/20 | 0.30 |
| ▸ | MMP12 | P39900 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3268931 | 0.88 | TUBB4A (0.37) | — | |
| SCHEMBL3267982 | 0.85 | MEN1 (0.34) | TYMSDHFR | |
| SCHEMBL3269983 | 0.85 | ALDH1A1 (0.34) | — | |
| SCHEMBL3269102 | 0.82 | PDPK1 (0.36) | TYMSDHFR | |
| SCHEMBL3268889 | 0.82 | MAPK8 (0.32) | — | |
| SCHEMBL3270359 | 0.81 | MMP1 (0.33) | MMP1MMP2MMP9MMP12 | |
| SCHEMBL3182168 | 0.81 | PTGS2 (0.39) | CCNCCDK8TYMSDHFRDDAH1 | |
| SCHEMBL3268792 | 0.81 | CDC7 (0.36) | CCNCCDK8TYMSDHFRDDAH1 | |
| SCHEMBL3268887 | 0.80 | PTGS1 (0.35) | — | |
| SCHEMBL3269989 | 0.79 | KDR (0.39) | TYMS |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1784409-B1 | SUBSTITUTED THIENOPYRROLE CARBOXYLIC ACID AMIDES, PYRROLOTHIAZOLE CARBOXYLIC ACID AMIDES, AND RELATED ANALOGS AS INHIBITORS OF CASEIN KINASE I EPSILON | AVENTIS PHARMA INC (US) | 2010-06-16 | — | — | EP | claimed |